1. Home
  2. ATS vs SLNO Comparison

ATS vs SLNO Comparison

Compare ATS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$28.02

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$33.73

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
SLNO
Founded
1978
1999
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.3B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
ATS
SLNO
Price
$28.02
$33.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$35.00
$108.00
AVG Volume (30 Days)
144.7K
1.3M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
108.90
EPS
N/A
0.39
Revenue
N/A
$1,450,788.00
Revenue This Year
$17.99
$155.44
Revenue Next Year
$3.91
$57.99
P/E Ratio
$222.92
$94.31
Revenue Growth
N/A
138.82
52 Week Low
$20.90
$32.63
52 Week High
$33.01
$89.12

Technical Indicators

Market Signals
Indicator
ATS
SLNO
Relative Strength Index (RSI) 32.23 32.72
Support Level $26.12 $32.63
Resistance Level $28.19 $44.60
Average True Range (ATR) 1.03 2.45
MACD -0.56 -0.18
Stochastic Oscillator 0.00 13.98

Price Performance

Historical Comparison
ATS
SLNO

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: